Top Markets
#1 Official Trump Official Trump +37.23%
#2 Tutorial Tutorial +31.74%
#3 Melania Meme Melania Meme +22.14%
#4 Siacoin Siacoin +22.01%
#5 Mubarak Mubarak +20.77%
#6 EXOD EXOD +18.93%
#7 MowCat MowCat +18.78%
#8 Unit Pump Unit Pump +18.05%
#9 Pump.fun Pump.fun +18.05%
#10 Unit Zcash Unit Zcash +15.05%
Coin of the day
Official Trump Official Trump
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Pozycja w akcjach #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Cena akcji
$1.81
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$77.00M
Zmiana (1 dzień)
1.30%
Zmiana (1 rok)
-23.63%
Kraj
US
Handel Annovis Bio, Inc. (ANVS)

Kategoria

Healthcare
Historia ceny akcji dla Annovis Bio, Inc. (ANVS)
Najwyższa cena zamknięcia: $1.82 dnia 2026-08-01

Najniższa cena zamknięcia: $7.71 dnia 2020-01-01
Historia cen akcji firmy Annovis Bio, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH